<mets:mets LABEL="Eprints Item" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-0.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" OBJID="oai:utas.edu.au:3971" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:mets="http://www.loc.gov/METS/"><mets:metsHdr CREATEDATA="2009-01-07T20:02:48Z"><mets:agent TYPE="ORGANIZATION" ROLE="CUSTODIAN"><mets:name>UTas ePrints</mets:name></mets:agent></mets:metsHdr><mets:dmdSec ID="DMD_oai:utas.edu.au:3971_mods"><mets:mdWrap MDTYPE="mods"><mets:xmlData><mods:titleInfo><mods:title>Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">DW</mods:namePart><mods:namePart type="family">Reid</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">N</mods:namePart><mods:namePart type="family">Misso</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">S</mods:namePart><mods:namePart type="family">Aggarwal</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">PJ</mods:namePart><mods:namePart type="family">Thompson</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">EH</mods:namePart><mods:namePart type="family">Walters</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic&#13;
fibrosis&#13;
REID DW, MISSO N, AGGARWAL S, THOMPSON PJ, WALTERS EH. Respirology 2007; 12: 63–69&#13;
Background and objective: In cystic fibrosis (CF) very few studies have assessed sputum 8-iso-&#13;
PGF2α levels during pulmonary exacerbations as a direct measure of airway oxidative stress. The role&#13;
of other lipid-derived inflammatory mediators, such as the cysteinyl leukotrienes (cys-LTs) and prostaglandin&#13;
(PG)-E2, during exacerbations is also poorly defined and the effect of conventional antibiotic&#13;
therapy on these components of the inflammatory process is unclear.&#13;
Methods: Sputum 8-iso-PGF2α, total cys-LT and PGE2 levels were measured in 17 CF patients experiencing&#13;
a pulmonary exacerbation and repeated analysis were performed in 15 of these patients&#13;
after antibiotic treatment. Eight stable CF and nine healthy subjects provided control data.&#13;
Results: Sputum 8-iso-PGF2α was significantly elevated in acute, but not stable CF patients versus&#13;
healthy controls (P &lt; 0.001). Similarly, sputum cys-LT and PGE2 levels were increased in acute compared&#13;
with stable CF patients and healthy controls (P ≤ 0.001). Although substantially lower than in&#13;
acute patients, sputum cys-LT levels in stable patients were also significantly higher than in normal&#13;
controls (P = 0.01). There were strong associations between cys-LT levels and sputum total cell&#13;
counts, and blood neutrophils in acute patients (r2 = 0.53, P = 0.001 and r2 = 0.33, P &lt; 0.05, respectively).&#13;
Overall in the CF patients, FEV1%predicted was strongly and negatively correlated with sputum&#13;
8-iso-PGF2α (r2 = 0.34, P = 0.006), cys-LT (r2 = 0.40, P = 0.002) and PGE2 (r2 = 0.52, P &lt; 0.001) levels.&#13;
Antibiotic treatment reduced sputum total cell count (P = 0.03), but did not affect 8-iso-PGF2α, cys-LT&#13;
or PGE2 levels.&#13;
Conclusions: CF exacerbations are characterized by increased oxidative stress and sputum concentrations&#13;
of bioactive lipid mediators. Treatment does not modulate these aspects of inflammation&#13;
and more targeted therapy needs further study.</mods:abstract><mods:classification authority="lcc">321027 Respiratory Diseases</mods:classification><mods:originInfo><mods:dateIssued encoding="iso8061">2007</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Wiley-Blackwell Publishing Asia</mods:publisher></mods:originInfo><mods:genre>Article</mods:genre></mets:xmlData></mets:mdWrap></mets:dmdSec><mets:amdSec ID="TMD_oai:utas.edu.au:3971"><mets:rightsMD ID="rights_oai:utas.edu.au:3971_mods"><mets:mdWrap MDTYPE="mods"><mets:xmlData><mods:useAndReproduction>
<p><strong>Permissions, Copyright and Authorship Statement</strong><br />
I grant the University of Tasmania permission to copy, store and
communicate this work  I declare that I either own the copyright in the
work or I am submitting this work with permission of the copyright owner
or under licence from the copyright owner. I declare that the metadata
regarding authorship are true and correct and that it complies with the
authorship requirements set down in the Joint NHMRC/AVCC Guidelines on
Research and Practice.</p>

<p>Clicking on the deposit button indicates your agreement to these 
terms.</p>
    </mods:useAndReproduction></mets:xmlData></mets:mdWrap></mets:rightsMD></mets:amdSec><mets:fileSec><mets:fileGrp USE="reference"><mets:file SIZE="120348" ID="oai:utas.edu.au:3971_4768_1" MIMETYPE="application/octet-stream" OWNERID="http://eprints.utas.edu.au/3971/1/3971.pdf"><mets:FLocat LOCTYPE="URL" xlink:href="http://eprints.utas.edu.au/3971/1/3971.pdf" xlink:type="simple"></mets:FLocat></mets:file></mets:fileGrp></mets:fileSec><mets:structMap><mets:div AMDID="TMD_oai:utas.edu.au:3971" DMDID="DMD_oai:utas.edu.au:3971_mods"><mets:fptr FILEID="oai:utas.edu.au:3971_4768_1"></mets:fptr></mets:div></mets:structMap></mets:mets>